Editor's Summaries of the Articles Published in This Issue of Precision Medicine Communications

Abstract

In this issue, Rehman et al., investigate the possible association of genetic polymorphisms with the antiplatelet response to clopidogrel, Ullah and his colleagues review the single nucleotide polymorphism-based algorithms for warfarin dosing,  Halima et al., discussed the Parkinson’s disease treatment and the role of genetic polymorphisms in the efficacy and adverse effects, and Inzemam and his colleagues reviewed the pharmacogenetics of fluoxetine, specifically discussing the genetic effects on its efficacy and adverse effects during treatment of the major depressive disorder.